Skip to main content

iBio, Inc.

IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420720

No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q3 2026, worth $44.3M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$56.4M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +7 vs. previous quarter
61
13F valueReported value at the end of Q3 2026
$44.3M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
$100.0K
−75.0% year over year
Net income, FY2026
-$33.0M
No comparable prior period
Free cash flow, FY2026
-$23.8M
No comparable prior period
Revenue, Q1 FY2027
$1.07M
+975.0% year over year

Revenue flow, FY2026

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2026: $33.0M (33044.0% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.03M
Shares sold short
Change
+300.4K
+8.1% vs. previous
Days to cover
7.15
At average daily volume

Superinvestors holding IBIO, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding IBIO at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by iBio, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 27, 2026 (view filing)Mar 261 dayBanjak MarcChief Legal OfficerPPurchase+13.9K$1.65+$23.0K+125.9%25.0K after2 lots
Mar 23, 2026 (view filing)Mar 194 daysDuran FelipeChief Financial OfficerPPurchase+24.8K$2.02+$50.2K+223.0%36.0K after
Mar 23, 2026 (view filing)Mar 194 daysBrenner MartinSee RemarksPPurchase+12.3K$2.02+$24.9K+67.4%30.7K after
Jan 13, 2025 (view filing)Jan 103 daysDuran FelipeChief Financial OfficerPPurchase+9.19K$2.72+$25.0K+471.8%11.1K after
Jan 13, 2025 (view filing)Jan 103 daysBrenner MartinSee RemarksPPurchase+9.19K$2.72+$25.0K+100.7%18.3K after
Jan 13, 2025 (view filing)Jan 103 daysBanjak MarcChief Legal OfficerPPurchase+9.19K$2.72+$25.0K+490.2%11.1K after
Jan 13, 2025 (view filing)Jan 103 daysArkowitz DavidDirectorPPurchase+18.4K$2.72+$50.0KNew position18.4K after
Jan 13, 2025 (view filing)Jan 103 daysClark William DDirectorPPurchase+1.84K$2.72+$5.00KNew position1.84K after
Jan 13, 2025 (view filing)Jan 103 daysParada Antonio Bernardino GuimaraesDirectorPPurchase+183.8K$2.72+$500.0KNew position183.8K after
Jan 13, 2025 (view filing)Jan 103 daysSender GaryDirectorPPurchase+9.19K$2.72+$25.0KNew position9.19K after

Top 10 13F holders, Q3 2026

See all 61 holders

The largest institutional positions in iBio, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding IBIO in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Silverarc Capital Management, LLC5,357,088$6.32M0.77%+1,836,598+52.2%Added
Affinity Asset Advisors, LLC4,130,427$4.87M0.28%+122,546+3.1%Added
Cormorant Asset Management, LP3,570,000$4.21M0.28%00.0%Unchanged
Vestal Point Capital, LP2,600,000$3.07M0.08%00.0%Unchanged
Woodline Partners LP2,238,450$2.64M0.01%+461,903+26.0%Added
Vanguard Capital Management LLC2,098,151$2.48M0.00%00.0%Unchanged
Frazier Life Sciences Management, L.P.1,953,467$2.31M0.06%00.0%Unchanged
Balyasny Asset Management LLC1,592,008$1.88M0.00%+421,115+36.0%Added
Ensign Peak Advisors, Inc1,565,758$1.85M0.00%−266,699−14.6%Reduced
Bank of America Corp1,488,537$1.76M0.00%+367,045+32.7%Added

Holders of 5% or more of IBIO

See all 10 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of iBio, Inc..

Largest holders of IBIO from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Cormorant Asset Management, LP13G/A9.99%5.12M shares0.00 ppfrom 9.99%Nov 14, 20253 filingsAug 14, 2026SEC
Affinity Asset Advisors, LLC13G/A9.99%5.07M shares0.00 ppfrom 9.99%Aug 26, 20255 filingsAug 13, 2026SEC
Silverarc Capital Management, LLC13G9.99%2.18M sharesNewNov 14, 20251 filingNov 14, 2025SEC
Adage Capital Management, L.P.13G9.99%2.18M sharesNewNov 13, 20251 filingNov 13, 2025SEC
Sirenia Capital Management LP13G9.90%11.6M sharesNewMay 15, 20261 filingMay 15, 2026SEC